Oncology Meeting Resources

European Multidisciplinary Conference in Thoracic Oncology 2011

24 Feb - 26 Feb, Lugano, Switzerland

EMCTO 2013

Please find below the links to all EMCTO 2011 presentations that have an abstract, slide set or webcast. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Search Meeting Resources by Keyword

 

 

 

 

Useful links

Presenter Presentation title Session title
Rolf A. Stahel Clinical trials and translational research in Europe – the role of ETOP Keynote lecture
Keith Kerr What can be achieved with present pathology? Diagnostics in lung cancer: Pathology and biology
Elisabeth Brambilla How to sub-classify adenocarcinoma of the lung Diagnostics in lung cancer: Pathology and biology
Fiona Blackhall What can we learn from circulating tumor cells, circulating DNA and stem cells? Diagnostics in lung cancer: Pathology and biology
Miquel Taron New tools in the molecular diagnostic of lung cancer Diagnostics in lung cancer: Pathology and biology
Michael Rolf Mueller A patient with resectable right-sided NSCLC and one suspect nodule on the left side Integration of staging procedures
Christophe Dooms A patient with resectable right-sided NSCLC and suspect right paratracheal lymph nodes Integration of staging procedures
Niels Reinmuth A patient with resectable NSCLC and a solitary suspect adrenal lesion Integration of staging procedures
Ramon Rami-Porta TNM quiz Integration of staging procedures
Ken O'Byrne Invited Discussant, Abstracts 60PD, 61PD Poster Discussion: Tumor biology & pathology, translational research, SCLC and mesothelioma
Cecile Le Pechoux Invited Discussant, Abstracts 68PD, 69PD, 96PD Poster Discussion: Tumor biology & pathology, translational research, SCLC and mesothelioma
Wilfried Eberhardt Early and locally advanced disease Presentation and discussion of the Lugano Consensus
Paul Baas Advanced NSCLC Presentation and discussion of the Lugano Consensus
Cesare Gridelli ESMO Recommendation 2011: Advanced NSCLC Presentation and discussion of the Lugano Consensus
Ping Yang Anaplastic Lymphoma Kinase (ALK) status and clinical outcomes by IHC and FISH: a retrospective study of never-smoker, adenocarcinoma lung cancer cases Poster Discussion: Tumor biology & pathology, translational research, SCLC and mesothelioma